You just read:

Elusys Therapeutics Announces That Manuscripts For Its Anthrax Antitoxin, ANTHIM® (obiltoxaximab) Injection, Have Been Accepted For Publication

News provided by

Elusys Therapeutics, Inc.

20 Jul, 2016, 11:59 ET